External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

Angiogenesis 2026

-
Coming soon
08:55 PM
Duration 8mins Virtual
Machine Learning-Based Volumetric Analysis of nAMD Biomarkers in TENAYA/LUCERNE
Mark Barakat

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
09:05 PM
Duration 8mins Virtual
Global Real-World Data With Faricimab▼ in nAMD and DME: The VOYAGER Study
Veeral Sheth

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
09:15 PM
Duration 8mins Virtual
Four-Year Outcomes of Faricimab▼ in nAMD: Safety and Efficacy Results From the AVONELLE-X Long-Term Extension Trial
Carl Danzig

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
09:25 PM
Duration 8mins Virtual
Faricimab▼ for Polypoidal Choroidal Vasculopathy: 1-Year Results from the Phase 3b/4 SALWEEN Trial
Gemmy Cheung

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
09:40 PM
Duration 8mins Virtual
Pagoda Trial Results Through Year 4: Port Delivery Platform with Ranibizumab for the Treatment of DME
Dante Pieramici

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
10:55 PM
Duration 8mins Virtual
Quantification of the OCT Biomarker Retinal Fluid in Diabetic Macular Edema Treated with Faricimab▼
Jennifer Lim

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar